Genetic variation linked to chemotherapy-related liver damage in patients with colorectal cancer liver metastases

A new international study led by Mayo Clinic researchers has identified a genetic factor that may explain why some patients with colorectal cancer that has spread to the liver experience more severe liver damage after chemotherapy.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup